Anixa Biosciences Inc share price logo

Anixa Biosciences Inc

NASDAQ: ANIX

Small Cap

$3.07

+0.07

(+2.33%)

as on

Anixa Biosciences Inc Stock Performance

as on May 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.85
    $3.09
    downward going graph

    7.17%

    Downside

    0.65%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.44
    $5.46
    downward going graph

    20.52%

    Downside

    77.74%

    Upside

    downward going graph

Anixa Biosciences Inc share price movements today

Previous Close
$3.00
Open
$2.94
Volume
288.5K
Day's Low - High
$2.85 - $3.09
52 Week Low - High
$2.44 - $5.46

Anixa Biosciences Inc Historical Returns

1 Month Return
+ 15.83 %
3 Month Return
+ 1.35 %
1 Year Return
+ 14.07 %
3 Year Return
-23.27 %
5 Year Return
-29.74 %

Anixa Biosciences Inc Stock Fundamentals & Key Indicators

Check Anixa Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$100.6M

EPS (TTM)

-0.38

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-13.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-68.07%

Anixa Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anixa Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$100.6M-29.74%NA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Anixa Biosciences Inc Stock including INR - Dollar returns

The Anixa Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anixa Biosciences Inc investment value today

Current value as on today

₹1,30,999

Returns

₹30,999

(+31%)

Returns from Anixa Biosciences Inc Stock

₹16,730 (+16.73%)

Dollar Impact

₹14,268 (+14.27%)

Analyst Recommendation on Anixa Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Anixa Biosciences Inc. Average target price of $10.75

Anixa Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Anixa Biosciences Inc.

What analysts predicted

71.44%UPSIDE

Target Price

$10.75

Current Price

$3.07

Analyzed by

7 Analysts

Target

$10.75

Anixa Biosciences Inc target price $10.75, a slight upside of 71.44% compared to current price of $3.07. According to 7 analysts rating.

Indian Investors' Interest in Anixa Biosciences Inc Stock

Search interest for Anixa Biosciences Inc Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:28% versus previous 30 day period

Anixa Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Total Revenue
0
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
0
0
0
0
Operating Income
-3
-3
-3
-3
-3
-3
-3
-2
-2
-2
EBITDA
-3
-3
-3
-3
-3
-3
-2
-2
-2
-2
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-3
-3
-3
-2
-3
-2
-2
-2
-2
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
-2
-3
-3
-3
-2
-3
-2
-2
-2
-2
Net Profit Margin
-1724.36%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Anixa Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Oct 2016
Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Total Revenue
0
0
1
0
-
0
2,469
0
-
-
Gross Profit
0
0
0
0
0
0
2,468
0
0
0
Operating Income
-4
-6
-13
-11
-9
-13
-13
-11
-13
-11
EBITDA
-4
-4
-13
-11
-10
-13
-13
-10
-12
-11
Interest Expense
0
0
-
-
0
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-5
-14
-11
-10
-13
-13
-9
-12
-11
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-5
-5
-13
-11
-10
-12
-13
-9
-12
-10
Net Profit Margin
-1672.14%
-1381.79%
-1258.07%
-4658.82%
0.00%
-2528.64%
-0.55%
-4671.90%
0.00%
0.00%

Anixa Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-3
-3
-3
-2
-3
-2
-2
-2
-2
Operating Cash Flow
-2
-2
-2
0
-2
-1
-1
-1
-2
Investing Cash Flow
0
2
2
0
2
2
0
0
1
Financing Cash Flow
2
0
0
0
0
0
1
0
1
Change in Cash
0
0
0
0
0
0
0
0
0

Anixa Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-5
-14
-11
-10
-13
-13
-9
-12
-11
Operating Cash Flow
-3
-4
-4
-6
-4
-6
-6
-7
-7
Investing Cash Flow
-2
1
0
0
-3
-10
-5
4
4
Financing Cash Flow
7
2
5
9
31
0
0
3
2
Change in Cash
0
0
0
2
22
-16
-11
0
0

Global Institutional Holdings in Anixa Biosciences Inc

Funds
Holdings
LPL Financial Corp
0.26%
Vanguard Group Inc
4.35%
Bank of America Corp
0.64%
Davidson D A & Co
1.61%
HighTower Advisors, LLC
0.12%

Anixa Biosciences Inc News & Key Events

  • img

    Today's Timeline - 16 September

    Tue, 07:10 PM

    -

    Anixa Biosciences stock has returned 51.7% this year, with EPS estimates rising 7.9% over the past three months.

    Tue, 10:00 PM

    -

    Anixa completes dosing in fourth cohort of Phase 1 ovarian cancer CAR-T trial, showing positive safety profile.

    Tue, 11:35 PM

    -

    Anixa reports improved financial performance, sufficient cash runway, and files US$200 million Shelf Registration for future funding.

Insights on Anixa Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ANIX stock has moved up by 11.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 19.1% return, outperforming this stock by 42.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 28.1% return, outperforming this stock by 12.7%

About Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
OrganisationAnixa Biosciences Inc
Headquarters3150 Almaden Expressway, San Jose, CA, United States, 95118
IndustryBiotechnology
CEODr. Amit Kumar Ph.D.
E-voting on sharesClick here to vote

Key Management of Anixa Biosciences Inc

Name

Title

Dr. Amit Kumar Ph.D.

CEO, Chairman & Co-Chair of CBAB

Mr. Michael J. Catelani CPA, MBA

President, COO, CFO & Corporate Secretary

Dr. Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

FAQs

What is Anixa Biosciences Inc share price today?

Anixa Biosciences Inc share price today is $3.07 as on at the close of the market. Anixa Biosciences Inc share today touched a day high of $3.09 and a low of $2.85.

What is the 52 week high and 52 week low for Anixa Biosciences Inc share?

Anixa Biosciences Inc share touched a 52 week high of $5.46 on and a 52 week low of $2.44 on . Anixa Biosciences Inc stock price today i.e. is closed at $3.07,which is 43.74% down from its 52 week high and 25.82% up from its 52 week low.

What is Anixa Biosciences Inc's market capitalisation today?

Anixa Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Anixa Biosciences Inc Stock (ANIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anixa Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anixa Biosciences Inc Shares that will get you 0.4886 shares as per Anixa Biosciences Inc share price of $3.07 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Anixa Biosciences Inc Stock (ANIX) from India?

Indian investors can start investing in Anixa Biosciences Inc (ANIX) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Anixa Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Anixa Biosciences Inc share’s latest price of $3.07 as on May 7, 2026 at 1:29 am IST, you will get 3.2573 shares of Anixa Biosciences Inc. Learn more about fractional shares .

What are the returns that Anixa Biosciences Inc has given to Indian investors in the last 5 years?

Anixa Biosciences Inc stock has given -29.74% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?